DELAYED INTESTINAL-ABSORPTION OF LEVOTHYROXINE

被引:112
作者
BENVENGA, S [1 ]
BARTOLONE, L [1 ]
SQUADRITO, S [1 ]
GIUDICE, FL [1 ]
TRIMARCHI, F [1 ]
机构
[1] UNIV MESSINA,SERV AUTONOMO ENDOCRINOL,I-98125 MESSINA,ITALY
关键词
D O I
10.1089/thy.1995.5.249
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report four female patients with nodular goiter (in two of the four due to Hashimoto's thyroidits) and one male patient with frank hypothyroidism due to Hashimoto's thyroiditis in whom TSH-suppressive or replacement L-T-4 therapy failed to suppress or, respectively, normalize serum TSH. As is typical in our country, our patients took L-T-4 15-20 min before a light breakfast, Gastrointestinal or other diseases and drugs known to interfere with the intestinal absorption of L-T-4 were not the cause of this failure, The gastrointestinal absorption test of L-T-4 (1000 mu g) was performed in four patients; in three patients it revealed peculiar abnormalities in that (i) the absorption peak was >70% but occurred at 4 hr vs an average of 2 hr in 12 euthyroid controls (EC) and 3 hr in 10 primary hypothyroid controls (HC); (ii) 50% of the maximal absorption occurred at 110 min vs 45 min in EC and 50 min in HC; (iii) the maximal increment in T-4 absorption was between 90 and 120 min (+111%) vs between 30 and 60 min in EC (+312%) and HC (+354%), In sum, only the first part of the absorption curve of T-4 was shifted to the right (in three of the four women) and this shift was more pronounced and extended to the second part of the curve in the fourth patient; in this last patient absorption peak was 44% at 180 min, Based on these results, we obtained full suppression or normalization of TSH by postponing breakfast for at least 60 min after T-4 ingestion. The precise cause for the ''inertia'' in the early phase of T-4 absorption is not known, but since it was observed in two patients with euthyroid nodular goiter, it is not associated with hypothyroidism per se.
引用
收藏
页码:249 / 253
页数:5
相关论文
共 16 条
[11]  
LARSEN PR, 1991, WILLIAMS TXB ENDOCRI, P357
[12]   LEVOTHYROXINE THERAPY IN PATIENTS WITH THYROID-DISEASE [J].
MANDEL, SJ ;
BRENT, GA ;
LARSEN, PR .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (06) :492-502
[13]   SUCRALFATE CAUSES MALABSORPTION OF L-THYROXINE [J].
SHERMAN, SI ;
TIELENS, ET ;
LADENSON, PW .
AMERICAN JOURNAL OF MEDICINE, 1994, 96 (06) :531-535
[14]  
SUZUKI Y, 1982, Folia Endocrinologica Japonica, V58, P1487
[15]  
TRIMARCHI F, 1983, J ENDOCRINOL INVEST, V6, P203, DOI 10.1007/BF03350609
[16]   ASPECTS OF ABSORPTION OF ORAL L-THYROXINE IN NORMAL MAN [J].
WENZEL, KW ;
KIRSCHSIEPER, HE .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1977, 26 (01) :1-8